Global Orthopedic Cell Therapy Market Size, Share, and COVID-19 Impact Analysis 2023-2029 MedCore - Includes: Platelet-rich Cell Therapy and 1 more

In 2022, the global orthopedic cell therapy market was valued at $470 million. This is anticipated to increase at a CAGR of 7.2% to reach $760 million over the forecast period.

The full report suite on the global market for orthopedic cell therapy includes platelet-rich cell therapy and bone marrow cell therapy.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Sports Medicine Procedure Volumes
• Market Forecasts Until 2029, and Historical Data to 2022
• Market Drivers & Limiters for each Sports Medicine market segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

PROCEDURE NUMBERS

Apart from the decline and recovery during 2020 and 202 because of the delay and cancellation of elective procedures, the total number of orthopedic cell therapy procedures is projected to grow at a mid-single-digit rate over the forecast period.

GLOBAL ORTHOPEDIC CELL THERAPY MARKET INSIGHTS

The orthopedic cell therapy market continues to grow steadily year after year largely due to the rising number of BMAC units sold. The COVID-19 pandemic did impact this market, leading to an overall decrease in procedures in 2020 and a consequent dip in market value. A rapid increase in market value was seen in 2022 in both the PRP and BMAC segments as the pandemic’s impact subsides, as patients who previously postponed surgeries were able to get elective surgeries again.

GLOBAL ORTHOPEDIC CELL THERAPY MARKET SHARE INSIGHTS

The global orthopedic bone cell therapy market is controlled by three main companies: Harvest Terumo, Zimmer Biomet, and Isto Biologics.

In 2022, Harvest Technologies was the frontrunner in the orthopedic cell therapy market. Harvest Technologies products include Harvest® BMAC and Harvest® PRP. Harvest Technologies also has an adipose tissue concentrator, Harvest® AdiPrep®, and its Harvest® SmartPrep multicellular processing system, which is capable of handling bone marrow, blood and adipose tissue for concentration.

GLOBAL ORTHOPEDIC CELL THERAPY MARKET SEGMENTATION SUMMARY

• Platelet-rich Cell Therapy Market
• Bone Marrow Cell Therapy Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2022

Forecast: 2023-2029

Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.